drugset / Trial / NCT03411980
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of the study is to evaluate the pharmacokinetics of vilaprisan in subjects with moderate to severe renal impairment compared with matched subjects with normal renal function.
Timeline
- Start
- 2018-02-02
- Primary completion
- 2018-10-10
- Completion
- 2019-02-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vilaprisan | Other / unclassified | 2 mg | Oral |